Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSZ2400030	戈利木单抗注射液	golimumab	Injection	Biological Products	License Renew	2024-05-25					view
JYSZ2400029	戈利木单抗注射液	golimumab	Injection	Biological Products	License Renew	2024-05-25					view
JYSB2400071	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2024-04-02					view
JYSB2400070	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2024-04-02					view
JYSB2300162	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2023-09-15					view
JYSB2300161	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2023-09-15					view
JXSL2300107	戈利木单抗注射液	golimumab	Injection	Biological Products(2.2)	Import Drug Application	2023-06-16					view
JYSB2200116	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2022-07-07					view
JYSB2200117	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2022-07-07					view
JXSL2200034	戈利木单抗注射液	golimumab	Injection	Biological Products(2.2)	Import Drug Application	2022-03-22					view
JYSB2101095	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-07-27					view
JYSB2101096	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-07-27					view
JYSB2100090	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-04-01	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2021-03-31	view
JYSB2100089	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-04-01	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2021-05-09	view
JYSB2100063	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-02-26	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2021-12-24	view
JYSB2100062	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2021-02-26	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2021-12-24	view
JYSB2000678	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-12-28	西安杨森制药有限公司	Xian Janssen Pharmaceutical Ltd	Certificate Issued	2021-12-17	view
JYSB2000679	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-12-28	Janssen Biologics B.V.	Janssen Biologics BV	In Review	2022-01-27	view
JYSB2000334	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2020-06-28	Janssen Biologics B.V.	Janssen Biologics BV	Filed	2020-07-01	view
JYSB1900231	戈利木单抗注射液	golimumab	Injection	Biological Products	Supplementary Application	2019-09-04	Janssen Biologics B.V.	Janssen Biologics BV	Certificate Issued	2020-08-18	view